Intriguingly, RelB has been shown to promote the growth of primary human fibroblast cells, and cells from chronic lymphocytic leukemia (CLL) patients, through regulating p53 stability, EZH2 expression and Rb activation [35]. Here, RB1 is linked to B-cell chronic lymphocytic leukemia.